Qin et al. found that neutralizing TGF-β with monoclonal antibodies in a co-culture of primed neutrophils and SW480 cells (colon adenocarcinoma cells) inhibited tumor cell migration and increased neutrophil cytotoxicity against tumor cells. The gene discussed is TGFB1; the disease is neoplasm.